Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 973.45
+3.70 (0.38%)
At close: Jun 5, 2026
Jubilant Pharmova Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 14% in FY 2026 with strong performance in CDMO Sterile Injectables, Generics, and Allergy Immunotherapy. FY 2027 will see margin pressure in H1 due to SPECT shortages, but recovery is expected in H2 as new manufacturing lines ramp up.